Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China
· Delayed Price · Currency is CNY 86.03
-0.95 (-1.09%)
At close: Mar 9, 2026
SHE:301093 Revenue
Jiangsu Hualan New Pharmaceutical Material had revenue of 132.48M CNY in the quarter ending September 30, 2025, a decrease of -4.72%. This brings the company's revenue in the last twelve months to 604.86M, up 2.18% year-over-year. In the year 2024, Jiangsu Hualan New Pharmaceutical Material had annual revenue of 586.41M, down -5.86%.
Revenue (ttm)
604.86M
Revenue Growth
+2.18%
P/S Ratio
22.93
Revenue / Employee
650.39K
Employees
930
Market Cap
13.87B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Micro-Tech (Nanjing) Co.,Ltd | 3.19B |
| Autek China | 1.82B |
| Tofflon Science and Technology Group | 5.22B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Eyebright Medical Technology (Beijing) | 1.48B |
| Tinavi Medical Technologies | 283.26M |
| Sansure Biotech | 1.65B |
| Winner Medical | 10.80B |